Related Experiment Videos
Dosing the newer antiarrhythmic drugs in children: considerations in pediatric pharmacology
The American Journal of Cardiology
|June 1, 1986
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Rugby players' satisfaction with custom-fitted mouthguards made with different materials.
Community dentistry and oral epidemiology·2001
The metrics process: Baylor's development of a "report card" for faculty and departments.
Academic medicine : journal of the Association of American Medical Colleges·1999
Clinical Factors Associated With Survival in In-Hospital Cardiac Arrest.
The American journal of cardiology·2026
When Swallowing Triggers VT.
The American journal of cardiology·2026
Clinical Implementation of Angiography-Derived Fractional Flow Reserve for Revascularization Guidance: Initial Multicenter United States Experience.
The American journal of cardiology·2026
Management of Antiplatelet Regimen During Surgical Procedures: a Report from the MARS Registry.
The American journal of cardiology·2026
In-Hospital Mortality After Aortic Valve Replacement Surgical Versus Transcatheter: A Nationwide Study with Machine Learning-Based Risk Prediction.
The American journal of cardiology·2026
Meta-Analysis: Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors for Gastroprotection in Patients Receiving Antiplatelet Therapy.
Alimentary pharmacology & therapeutics·2026
Current practices, challenges, and future directions in subcutaneous oncology monoclonal antibody delivery: a qualitative study.
Expert opinion on drug delivery·2026
Ensuring patient rights, safety, and welfare in "compassionate use" of drugs.
Perspectives in clinical research·2026
Pediatric obesity pharmacotherapy: a practical guide for general pediatricians.
Current opinion in pediatrics·2026
Old Drugs, New Targets: Molecular Docking Insights into Repurposing Proton Pump Inhibitors for the TLR4/MD-2, NLRP3, and C5aR1 Axes in Autoimmune Liver Diseases.
Pharmaceuticals (Basel, Switzerland)·2026